Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released May 2, 2018, after the close
10-Q filed May 2, 2018, 32 days after period end · 0001299130-18-000031
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | $19.36M | $24.92M | $19.13M | $17.65M |
| Net Income | -$24.18M | -$23.87M | -$19.35M | -$20.17M |
| EPS Diluted | -$0.20 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.23 |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
